当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析

亿帆医药

(002019)

  

流通市值:111.16亿  总市值:160.12亿
流通股本:8.51亿   总股本:12.26亿

亿帆医药(002019)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.18亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益834920.65万元,未分配利润435017.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产1178116.35万元,负债343195.70万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,325,969,392.934,068,107,333.942,930,281,528.531,944,049,304.17
营业总成本1,189,455,724.434,041,933,714.512,757,500,720.621,797,130,144.57
营业利润158,852,659.01-882,712,179.27125,123,271.54102,583,568.51
利润总额158,913,831.86-869,030,706.91134,770,671.98103,701,675.29
净利润117,548,462.21-885,649,347.05101,104,513.8184,672,475.83
其他综合收益-13,919,671.4951,238,166.3525,497,648.6560,181,819.72
综合收益总额103,628,790.72-834,411,180.7126,602,162.46144,854,295.55
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,537,066,066.193,251,142,647.733,282,755,933.793,532,010,972.23
非流动资产合计8,244,097,394.438,248,443,134.419,064,185,535.239,048,146,618.3
资产总计11,781,163,460.6211,499,585,782.1412,346,941,469.0212,580,157,590.53
流动负债合计2,477,132,851.942,187,361,855.832,022,326,994.282,064,855,469.04
非流动负债合计954,824,141.881,057,317,396.671,058,311,667.741,229,904,268.26
负债合计3,431,956,993.823,244,679,252.53,080,638,662.023,294,759,737.3
归属于母公司股东权益合计8,407,491,100.058,275,633,622.038,985,606,476.428,981,727,050.21
股东权益合计8,349,206,466.88,254,906,529.649,266,302,8079,285,397,853.23
负债和股东权益合计11,781,163,460.6211,499,585,782.1412,346,941,469.0212,580,157,590.53
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,331,400,523.174,588,266,174.113,370,412,281.332,245,728,452.34
经营活动现金流出小计1,150,560,798.694,239,681,382.223,112,956,707.142,092,289,902.05
经营活动产生的现金流量净额180,839,724.48348,584,791.89257,455,574.19153,438,550.29
投资活动现金流入小计70,498,284.231,458,656,473.941,165,805,574.1844,696,492.08
投资活动现金流出小计146,769,345.11,991,491,762.741,160,353,242.6820,967,894.39
投资活动产生的现金流量净额-76,271,060.87-532,835,288.85,452,331.523,728,597.69
筹资活动现金流入小计425,501,377.92,206,723,182.651,385,534,721.481,177,563,441.94
筹资活动现金流出小计411,632,990.392,175,945,882.031,689,928,894.481,270,810,766.72
筹资活动产生的现金流量净额13,868,387.5130,777,300.62-304,394,173-93,247,324.78
汇率变动对现金及现金等价物的影响-2,343,126.3714,593,451.0712,841,118.0817,292,154.85
现金及现金等价物净增加额116,093,924.75-138,879,745.22-28,645,149.23101,211,978.05
期末现金及现金等价物余额688,839,805.94572,745,881.19682,980,477.18812,837,604.46
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国盛证券张金洋,胡偌碧0.450.580.752024-04-25
太平洋周豫0.470.700.882024-04-24
国盛证券张金洋,胡偌碧0.470.590.772024-04-21
华安证券谭国超0.550.811.032024-04-21
太平洋周豫0.450.63--2024-04-08
TOP↑